2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Emapalumab: new trials by email Literature Review of Emapalumab trials Research Report on Emapalumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant Biospecimen Collection, Busulfan, Computed Tomography - Acute Myeloid Leukemia, Graft Versus Host Disease | Phase 1 | Recruiting | City of Hope Medical Center | 15 | 2026-06-12 | 2026-07-01 |
| A Study to Evaluate Emapalumab in Japanese Healthy Volunteers. NI-0501, Saline - Rare Diseases | Phase 1 | Completed | Swedish Orphan Biovitrum | 8 | 2021-01-14 | 2023-11-30 |
| First in Human Study of an Anti-IFN Gamma Monoclonal Antibody in Healthy Volunteers NI-0501, Placebo - Healthy Volunteers | Phase 1 | Completed | Swedish Orphan Biovitrum | 20 | 2011-09-01 | 2023-08-09 |
Graft vs Host Disease (1) · Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1) · Rare Diseases (1)
Swedish Orphan Biovitrum (2) · City of Hope Medical Center (1)
Japan (1) · United Kingdom (1) · United States (1)
Amandeep Salhotra (1) · Kenichi Furihata, MD, PhD (1) · Peter Dewland, MD (1) · Steve Warrington, MD (1)
P30CA033572 (1)